Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Unilever PLC (ULVR)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
44.58 +0.35    +0.79%
06:15:48 - Delayed Data. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  GB00B10RZP78 
WKN:  A0JNE2
  • Volume: 9,535
  • Bid/Ask: 44.56 / 44.60
  • Day's Range: 44.12 - 44.61
Unilever 44.58 +0.35 +0.79%

AS:ULVR Financials

 
A brief overview of the AS:ULVR financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Unilever PLC over time.

Unilever PLC reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 59,604 million compared to EUR 60,073 million a year ago. Net income was EUR 6,487 million compared to EUR 7,642 million a year ago. Basic earnings per share from continuing operations was EUR 2.58 compared to EUR 3 a year ago. Diluted earnings per share from continuing operations was EUR 2.56 compared to EUR 2.99 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

ULVR Income Statement

Gross margin TTM 42.24%
Operating margin TTM 16.89%
Net Profit margin TTM 10.88%
Return on Investment TTM 15.07%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 15214 15214
Gross Profit 15214 15214
Operating Income 2410.5 2410.5 2637.5 2637.5
Net Income 1774 1774

ULVR Balance Sheet

Quick Ratio MRQ 0.42
Current Ratio MRQ 0.76
LT Debt to Equity MRQ 129.68%
Total Debt to Equity MRQ 163.64%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 78409 78409
Total Liabilities 56488 56488
Total Equity 21921 21921

ULVR Cash Flow Statement

Cash Flow/Share TTM 3.77
Revenue/Share TTM 23.85
Operating Cash Flow  -
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 1683 1683
Cash From Investing Activities -100 -100
Cash From Financing Activities -1244.5 -1244.5
Net Change in Cash 322.5 322.5
* In Millions of EUR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

ULVR Comments

Write your thoughts about Unilever Plc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
المحامي فراس ابوجمل
المحامي فراس ابوجمل Jan 19, 2024 10:15AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
sell
Reply
0 0
Report
Miguel CastelloGenoves
Calati Jul 11, 2023 7:06PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Unilever or Procter and Gamble? Thank you
Reply
0 0
Report
Frank Van den Brink
StormTrader Jun 10, 2022 3:09AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Will go below 40. One board is not improving the results or the outlook.
Reply
2 1
Report
RF RF
RF RF Mar 03, 2022 10:42AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
We therefore do not intend to pursue major acquisitions in the foreseeable future and will conduct a share buyback programme of up to €3 billion over the next two years.https://www.unilever.com/files/5b9872cf-337a-4bb4-9692-02a1b0a1b7fe/ir-q4-2021-full-announcement.pdf
Reply
3 1
Report
Umberto Sandroni
Umberto Sandroni Jan 24, 2022 4:44AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
a BUY signal on Market Mìracle advisor with target 48.67
Reply
3 0
Report
sinai levi
sinai levi Jan 19, 2022 7:56AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
this a long-term short
Reply
1 6
Report
Rohidas Kamath
Rohidas Kamath Jan 18, 2022 10:09AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I dont understand the mentality of investing public. uniliver plc went down yesterday even though its bid was rejected by gsk. today again it is down by nearly 3% for no reason. in fact uniliver plc should have recovered all the price of 7% that occured yesterday.
Reply
1 0
Report
Alexander Lanzinger
Alexander Lanzinger Jan 18, 2022 10:09AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Its because unilever will raise its bid.
Reply
0 2
Report
RF RF
RF RF Jan 18, 2022 10:09AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
no no
Reply
0 0
Report
Rohidas Kamath
Rohidas Kamath Jan 18, 2022 8:35AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I think uniliver plc is hell bent to persue takeover of consumer business from GSK against the wishes of majority shareholders. that is why share is beaten down.
Reply
0 0
Report
Rohidas Kamath
Rohidas Kamath Jan 17, 2022 10:22AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
uniliver plc is victim of rumour mongers. when gsk has rejected the offer of uniliver plc where is the question of takeover of consumer division. shareholders are worried about higher consideration that may be offered by uniliver plc. under the circumstances it will be very difficult for uniliver plc to proceed further.
Reply
3 0
Report
Rohidas Kamath
Rohidas Kamath Jan 17, 2022 9:52AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I think market has realised that uniliver plc will find it very difficult to acquire consumer division of GSK. That is why share is recovering. in that way hindustan uniliver is lucky to grab the consumer division of gsk in 2020 itself. Great salute to management of hindustan uniliver in india.
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email